Prevalence and management of hyperglycaemia in patients given thrombolysis for acute coronary syndromes

K C R Baynes, C McIntosh, M D Feher

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

The prevalence of hyperglycaemia in patients given thrombolysis for suspected acute myocardial infarction has not been clearly established. This is a retrospective case-note study of 69 consecutive patients who received thrombolysis on admission to a coronary care unit over a 15-month period. Admission plasma glucose > 7.8 mmol/L was observed in 46%, whilst a random glucose > 11.0 mmol/L was recorded in 22% of the group. A history of type 2 diabetes was present in 19%; with a glucose > 11.0 mmol/L being recorded in 61% on admission. Intravenous insulin therapy was administered to 43% of those without a history of diabetes, but presentation hyperglycaemia in the diabetic range, whereas 88% of known diabetic patients were treated with insulin. Hyperglycaemia/glucose intolerance, although commonly observed in patients thrombolysed for acute myocardial infarction, is not always managed with insulin therapy. There is a need for clear diabetes management protocols for all teams managing patients in coronary care units
Original languageEnglish
Pages (from-to)346 - 348
Number of pages3
JournalBritish Journal of Diabetes and Vascular Disease
Volume3
Issue number5
DOIs
Publication statusPublished - Sept 2003

Fingerprint

Dive into the research topics of 'Prevalence and management of hyperglycaemia in patients given thrombolysis for acute coronary syndromes'. Together they form a unique fingerprint.

Cite this